In the latest trading session, Hologic (HOLX) closed at $71.74, marking a -0.49% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.22% for the day.

Shares of Hologic Inc. HOLX shed 0.49% to $71.74 Thursday, on what proved to be an all-around poor trading session for the ...

Evercore ISI lowered the firm’s price target on Hologic (HOLX) to $76 from $81 and keeps an In Line rating on the shares. In the firm’s 2025 ...

The Police is aware of recent sightings of potential drone activity throughout the state.  The operation of a drone is a legal activity.  If there is an occasion […] The post Police Urges Public to ...

Hologic (NASDAQ:HOLX) has recalled its implantable BioZorb and BioZorb LP Markers over concerns that they can cause irritation, infection and other health complications. The FDA said the devices ...

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the “ ...

MARLBOROUGH, Mass., December 18, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #H5N1--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease ...

Analyst Doug Schenkel said that Tempus has a broad and growing menu and Twist Bio has developed a novel DNA synthesis platform. He set $60 price targets for those companies.

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.